US Patent 11291693 Bacteria engineered to treat metabolic diseases
Patent 11291693 was granted and assigned to Synlogic on April, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Adam Fisher0
Dean Falb0
Jonathan W. Kotula0
Paul F. Miller0
Sarah Rowe0
Vincent M. Isabella0
Yves Millet0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 10 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Apr, 2022
Golden AI
Edits made to:
Infobox (+20 properties)
Article (+130 characters)
US Patent 11291693 Bacteria engineered to treat metabolic diseases
Article
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of attenuating metabolic diseases are disclosed.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11291693
Date of patent
April 5, 2022
Patent application number
15738174
Date Filed
June 24, 2016
Patent primary examiner
Find more entities like US Patent 11291693 Bacteria engineered to treat metabolic diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.